Circulating endothelial progenitor cells after kidney transplantation

American Journal of Transplantation

Volumn 5, Issue 9, 2005, Pages 2154-2159

  Soler, María José ^a   Martínez Estrada, Ofelia María ^b   Puig Marí, Josep Maria ^a   Marco Feliu, Didac ^b   Oliveras, Anna ^a   Vila, Joan ^c   Mir, Marisa ^a   Orfila, Antonia ^a   Vilaró, Senén ^b   Lloveras, Josep ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Cardiovascular risk; Endothelial progenitor cells; Kidney transplantation

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CELL CULTURE; CELL PROLIFERATION; CIRCULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; STEM CELL;

ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD45; BODY WEIGHT; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GLOMERULAR FILTRATION RATE; GLYCOPROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LINEAR MODELS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NEUTROPHILS; PEPTIDES; REGRESSION ANALYSIS; SEX FACTORS; STEM CELLS; TIME FACTORS;

EID: 27844528911     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01010.x     Document Type: Article

References (26)

1. Satyan S, Rocher LL. Impact of kidney transplantation on the progression of cardiovascular disease. Adv Chronic Kidney Dis 2004; 11:274-293.
2. Margas A, Zilmer M, Fellström B. Endothelium-dependentvasodilation an oxidative stress in chronic renal failure: impact on cardiovascular disease. Kidney Int 2003; 63: S50-S53.
3. Eknoyan G. On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes. Am J Kidney Dis 1998; 32: S1-S4.
4. Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998; 338: 1428-1437.
5. Bro S, Brentzon JF, FaIk E, Andersen CB, Olgaard K, Nielsen LB. Chronic renal failure accelerates atherogenesis in apolipoprotein e-deficient mice. J Am Soc Nephrol 2003; 14: 2466-2474.
6. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 2003; 348: 593-600.
7. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
8. Lin Y, Weisdorf DJ, Solovey A, Hebbel RT. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 108: 399-405.
9. Peichev M, Naiyer AJ, Pereira D etal. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
10. Hristov M, Erl W, Weber PC. Endothelial progenitor cells, mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003; 23: 1185-1189.
11. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Defective vasculogenesis in systemic sclerosis. Lancet 2004; 364: 603-610.
12. Urbich C, Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 2005; 67: 1672-1676.
13. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
14. Eizawa T, Murakami Y, Matsui K et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 2003; 19: 627-633.
15. Choi Jh, Kim K, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vas Biol 2004; 24: 1-9.
16. Groot K, Bahlmann FH, Sowa J et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66: 641-646.
17. Dimmeler S, Aicher A, Vasa M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the Pl 3-kinase/Akt pathway. J Clin Invest 2001; 108: 391-397.
18. Walter DH, Rittig K, Bahlmann FH et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002; 105: 3017-3024.
19. Werner N, Junk S, Laufs U et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003; 93: 17-24.
20. Ishikawa M, Asahara T. Endothelial progenitor cell culture for vascular regeneration. Stem Cells Dev 2004; 13: 344-349.
21. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med 1999; 340: 115-126.
22. Heeschen C, Lehmann R, Honold J et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004; 109: 1615-1622.
23. Ghani U, Shuaib A, Salam A et al. Stroke. Endothelial progenitor cells during cerebrovascular disease. Stroke 2005; 36: 151-153.
24. Butzal M, Loges S, Schweizer M et al. Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. Exp Cell Res 2004; 300: 65-71.
25. Gregory CR, Pratt RE, Huie P et al. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. Transplant Proc 1993; 25: 770-771.
26. Hauser I, Renders L, Radeke H, Sterzel R, Goppelt-Struebe M. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 1999; 14: 58-63